• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种治疗四肢原发性恶性黑色素瘤(Clark IV级和V级,厚度1.5毫米及以上)方法的比较。采用或不采用辅助区域灌注的广泛手术切除。

Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.

作者信息

Martijn H, Schraffordt Koops H, Milton G W, Nap M, Oosterhuis J W, Shaw H M, Oldhoff J

出版信息

Cancer. 1986 May 15;57(10):1923-30. doi: 10.1002/1097-0142(19860515)57:10<1923::aid-cncr2820571006>3.0.co;2-e.

DOI:10.1002/1097-0142(19860515)57:10<1923::aid-cncr2820571006>3.0.co;2-e
PMID:3955499
Abstract

A comparative retrospective study of patients with primary malignant melanomas of the extremities, Clark level IV/V and tumor thickness greater than or equal to 1.5 mm, was performed in Sydney (Australia) and Groningen (The Netherlands). The efficacy of wide local excision combined with adjuvant regional perfusion (Groningen) was compared with that of wide surgical excision only (Sydney). Patients were classified by sex and tumor location. There were only sufficient numbers of female patients with a tumor of the lower extremity available for this comparative study. All patients were stage I and none received prophylactic lymph node dissection. Age, tumor location, tumor thickness, depth of infiltration and ulceration were taken into account and the factors studied within this group were 10-year disease-free rate, 10-year survival rate, and local and regional recurrences. Women with a melanoma of the leg (excluding the foot) who had been treated by excision and adjuvant regional perfusion, had a significantly better 10-year disease-free rate (P less than 0.0005), a significantly higher 10-year survival rate (0.010 less than P less than 0.025) and significantly fewer local/regional recurrences (P less than 0.0005) than women treated by wide local excision only. For tumors of the foot, however, no significant differences in 10-year disease-free rate, 10-year survival rate or local/regional recurrences were observed after perfusion.

摘要

在悉尼(澳大利亚)和格罗宁根(荷兰)对四肢原发性恶性黑色素瘤患者进行了一项比较性回顾性研究,这些患者的克拉克分级为IV/V级,肿瘤厚度大于或等于1.5毫米。将广泛局部切除联合辅助区域灌注(格罗宁根)的疗效与仅进行广泛手术切除(悉尼)的疗效进行了比较。患者按性别和肿瘤位置进行分类。只有足够数量的下肢肿瘤女性患者可用于这项比较研究。所有患者均为I期,且均未接受预防性淋巴结清扫。考虑了年龄、肿瘤位置、肿瘤厚度、浸润深度和溃疡情况,该组研究的因素包括10年无病生存率、10年生存率以及局部和区域复发情况。接受切除和辅助区域灌注治疗的腿部(不包括足部)黑色素瘤女性患者,其10年无病生存率显著更高(P<0.0005),10年生存率显著更高(0.010<P<0.025),局部/区域复发显著更少(P<0.0005),而仅接受广泛局部切除治疗的女性患者则不然。然而,对于足部肿瘤,灌注后10年无病生存率、10年生存率或局部/区域复发情况未观察到显著差异。

相似文献

1
Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.两种治疗四肢原发性恶性黑色素瘤(Clark IV级和V级,厚度1.5毫米及以上)方法的比较。采用或不采用辅助区域灌注的广泛手术切除。
Cancer. 1986 May 15;57(10):1923-30. doi: 10.1002/1097-0142(19860515)57:10<1923::aid-cncr2820571006>3.0.co;2-e.
2
Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.关于肢体I期黑色素瘤辅助性区域隔离灌注的争议。
World J Surg. 1992 Mar-Apr;16(2):241-5. doi: 10.1007/BF02071527.
3
Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone.肢体孤立灌注治疗肢体局限性黑色素瘤。广泛局部切除联合肢体孤立灌注与单纯广泛局部切除的配对比较。
Arch Surg. 1990 Mar;125(3):317-21. doi: 10.1001/archsurg.1990.01410150039008.
4
[Preventive lymph node excision in the treatment concept of melanoma of the extremities].[预防性淋巴结切除在肢体黑色素瘤治疗理念中的应用]
Zentralbl Chir. 1996;121(6):474-7.
5
[Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].[对厚度超过1.5毫米的I期黑色素瘤患者肢体进行辅助性区域隔离灌注]
Ned Tijdschr Geneeskd. 1990 Oct 20;134(42):2042-7.
6
Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.肢体I期恶性黑色素瘤(Clark分级IV/V级且厚度超过1.5毫米)患者区域灌注后的局部复发与生存情况
Cancer. 1981 Nov 1;48(9):1952-7. doi: 10.1002/1097-0142(19811101)48:9<1952::aid-cncr2820480907>3.0.co;2-x.
7
Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.美法仑辅助性区域隔离灌注治疗肢体克拉克V级黑色素瘤患者。
J Surg Oncol. 1993 Apr;52(4):249-54. doi: 10.1002/jso.2930520411.
8
Hyperthermic perfusion in malignant melanoma: 5-year results.恶性黑色素瘤的热灌注治疗:5年结果
Recent Results Cancer Res. 1983;86:229-38. doi: 10.1007/978-3-642-82025-0_39.
9
Prognostic factors for survival in malignant melanoma of the eyelid skin.眼睑皮肤恶性黑色素瘤生存的预后因素。
Ophthalmic Plast Reconstr Surg. 2000 Jul;16(4):250-7. doi: 10.1097/00002341-200007000-00002.
10
[Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].[肢体原发性恶性黑色素瘤的区域灌注治疗。(根据克拉克分级为微分期IV/V且肿瘤厚度超过1.5毫米)]
Hautarzt. 1982 Sep;33(9):506-10.

引用本文的文献

1
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.肢体软组织肉瘤、途中转移瘤及其他不可切除肿瘤的隔离肢体灌注:优点、缺点及未来展望
Curr Oncol Rep. 2001 Jul;3(4):359-67. doi: 10.1007/s11912-001-0090-8.
2
Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines.热灌注隔离肢体可增加循环中炎症细胞因子的水平。
Cancer Immunol Immunother. 1995 Apr;40(4):272-75. doi: 10.1007/BF01519902.
3
Isolated regional perfusion in malignant melanoma of the extremities.
肢体恶性黑色素瘤的孤立区域灌注。
World J Surg. 1987 Aug;11(4):527-33. doi: 10.1007/BF01655819.
4
Cure and cosmesis in the management of primary malignant melanoma.原发性恶性黑色素瘤治疗中的治愈与美容
Br J Cancer. 1990 Feb;61(2):192-4. doi: 10.1038/bjc.1990.36.
5
Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
Cancer Chemother Pharmacol. 1991;27(5):379-84. doi: 10.1007/BF00688861.
6
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.美法仑隔离肢体灌注治疗恶性黑色素瘤的药代动力学优势。
Br J Cancer. 1992 Jul;66(1):159-66. doi: 10.1038/bjc.1992.235.
7
Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.关于肢体I期黑色素瘤辅助性区域隔离灌注的争议。
World J Surg. 1992 Mar-Apr;16(2):241-5. doi: 10.1007/BF02071527.